Medical Countermeasures New Mutation and DNA Repeats Behind Ceftazidime Resistance in Melioidosis BacteriumGlobal Biodefense StaffSeptember 5, 2025
Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
Medical Countermeasures Pan-Coronavirus Drug Discovery Gets a Boost from Global AI Blind ChallengeGlobal Biodefense StaffJuly 28, 2025
Soligenix Wins Additional 4.3M to Advance Ricin Vaccine Manufacturing Contracts + Grants May 5, 2016 …
BARDA Awards Contract to Basilea for Broad-Spectrum Antibiotic Antimicrobial Resistance April 22, 2016 …